細胞治療 CLDX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 27.16 | 107.18 | -1.23 | -87,153 | -81 | |
| 2025Q3 | 25.87 | 109.80 | -1.01 | -73,617 | -67 | |
| 2025Q2 | 20.35 | 112.82 | -0.85 | -63,858 | -57 | |
| 2025Q1 | 18.15 | 116.62 | -0.81 | -62,739 | -54 | |
| 2024Q4 | 25.27 | 118.97 | -0.71 | -56,027 | -47 | |
| 2024Q3 | 33.99 | 123.75 | -0.64 | -52,126 | -42 | |
| 2024Q2 | 37.01 | 129.23 | -0.54 | -46,317 | -36 | |
| 2024Q1 | 41.97 | 123.77 | -0.56 | -40,608 | -33 | |
| 2023Q4 | 39.66 | 109.98 | -0.84 | -47,627 | -43 | |
| 2023Q3 | 27.52 | 107.79 | -0.81 | -41,239 | -38 | |
| 2023Q2 | 33.93 | 108.86 | -0.65 | -33,205 | -31 | |
| 2023Q1 | 35.98 | 110.59 | -0.62 | -32,471 | -29 | |
| 2022Q4 | 44.57 | 105.28 | -0.57 | -27,885 | -26 | |
| 2022Q3 | 28.11 | 103.41 | -0.57 | -27,696 | -27 | |
| 2022Q2 | 26.96 | 101.09 | -0.77 | -36,396 | -36 | |
| 2022Q1 | 34.06 | 100.90 | -0.49 | -23,257 | -23 | |
| 2021Q4 | 38.64 | 100.95 | -0.43 | -20,340 | -20 | |
| 2021Q3 | 53.99 | 100.71 | -0.45 | -20,825 | -20 | |
| 2021Q2 | 33.44 | 100.49 | -0.34 | -13,439 | -13 | |
| 2021Q1 | 20.60 | 100.61 | -0.42 | -16,639 | -17 |